In a study performed in a small cohort of patients with MASLD, Kohjima et al. (37) reported an increase in the hepatic expression levels of ACACA (which encodes ACC1), along with unchanged levels of ACACB (ACC2-encoding gene) (37). The gene discussed is ACACB; the disease is metabolic dysfunction-associated steatotic liver disease.